Department of Clinical Medicine

Infectious Diseases

Publications

Sort by: Date | Author | Title

Hamm, S. R., Ekenberg, C., Schultz, H. H. L., Larsen, L., Skov, K., Helleberg, M., Jensen-Fangel, S., Harboe, Z. B., Larsen, C. S. & Nielsen, S. D. (2025). Vaccination ved organtransplantation. Ugeskrift for Læger, 187(46), 1-9. https://doi.org/10.61409/V03250242
Larsen, C. S., Andersen, P. H., Nielsen, L. P. & Helleberg, M. (2025). Vaccination ved rejser. Ugeskrift for Læger, 2025(187), Article V04250247. https://doi.org/10.61409/V04250247
Hønge, B. L., Hansen, K. S., Thomsen, M. K., Østergaard, L., Mogensen, T. H., Storgaard, M., Erikstrup, C. & Sørup, S. (2025). Validation of ICD-10 diagnostic coding for influenza in the Danish National Patient Registry. Annals of Epidemiology, 102, 62-67. https://doi.org/10.1016/j.annepidem.2024.12.017
Lende, S. S. F., Rothemejer, F. H., Andreas, M., Pedersen, M. L., Traberg-Nyborg, L., Iversen, E. F., Juhl, A. K., Søgaard, O. S., Schleimann, M. H. & Tolstrup, M. (2025). Vectored long-term co-delivery of antibodies for SARS-CoV-2, RSV and Influenza prophylaxis. Virology, 610, Article 110573. https://doi.org/10.1016/j.virol.2025.110573
Rodriguez-Morales, A. J., Alhazmi, A. H., Katime, A., Hameed, A. A., Morales, A., Lepetic, A. C., Risquez, A., Forero-Delgadillo, A. J., Holguin, A., Faccini-Martínez, Á. A., Guerrero, A., Ribeiro, A., Al Balushi, A., Taylan Ozkan, A., Rathish, B., Diaz, B., Porras-Pedroza, B. E., Hunsajarupan, B., Lakatos, B. ... SLAMVI, ESGITM, EVASG, ALEIMC, GEPI-SEIMC, SEMEVI, and CMTZMV-ACIN (2025). Yellow fever in South America – A plea for action and call for prevention also in travelers from SLAMVI, ESGITM, EVASG, ALEIMC, GEPI-SEIMC, SEMEVI, and CMTZMV-ACIN. Travel Medicine and Infectious Disease, 67, Article 102871. https://doi.org/10.1016/j.tmaid.2025.102871
Dahl, V. N., Burke, A., Fløe, A., Bruchfeld, J., Schön, T., Wejse, C. M., Andersen, A. B., Svensson, E., Ingen, J. V. & Forsman, L. D. (2024). Advantages and limitations of virtual multi-disciplinary team meetings on difficult-to-treat mycobacteria. International Journal of Tuberculosis and Lung Disease, 28(4), 212-213. https://doi.org/10.5588/ijtld.23.0551
Petersen, M. E., Hansen, L. K., Mitkin, A. A., Kelly, N. M., Wood, T. K., Jørgensen, N. P., Østergaard, L. J. & Meyer, R. L. (2024). A high-throughput assay identifies molecules with antimicrobial activity against persister cells. Journal of Medical Microbiology, 73(7), Article 001856. https://doi.org/10.1099/jmm.0.001856
the EuroSIDA study group (2024). All-cause and AIDS-related mortality among people with HIV across Europe from 2001 to 2020: impact of antiretroviral therapy, tuberculosis and regional differences in a multicentre cohort study. The Lancet Regional Health - Europe, 44, 100989. Article 100989. https://doi.org/10.1016/j.lanepe.2024.100989
Pedersen, O. S., Rudolf, F., Johansen, I. S., Andersen, Å. B., Lillebæk, T., Wejse, C. M. & Dahl, V. N. (2024). Antibiotikaresistens udgør en betydelig trussel mod bekæmpelsen af tuberkulose. Ugeskrift for Læger, 186(10), 1-8. Article V11230698. https://doi.org/10.61409/V11230698
Timmermann, A., Johansen, I. S., Tolstrup, M., Heilmann, C., Budtz-Jørgensen, E., Tolstrup, J. S., Nielsen, F. & Grandjean, P. (2024). Antibody response to SARS-CoV-2 mRNA vaccination in Danish adults exposed to perfluoroalkyl substances (PFASs): The ENFORCE study. Environmental Research, 263(Pt 1), Article 120039. https://doi.org/10.1016/j.envres.2024.120039

Displaying results 231 to 240 out of 2082

Previous

20

21

22

23

24

25

26

27

28

29

Next

Revised 11.09.2025
-
Lotte Bjerregaard Snabe